- Home
- SPNT vs DYN Comparison
SPNT vs DYN Comparison
Compare SPNT & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPNT | DYN |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | Property-Casualty Insurers | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2013 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SPNT | DYN |
|---|---|---|
| Price | $25.53 | $15.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 17 |
| Target Price | $28.75 | ★ $35.73 |
| AVG Volume (30 Days) | 1.0M | ★ 3.1M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 250.00 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $3,205,100,000.00 | N/A |
| Revenue This Year | $3.57 | N/A |
| Revenue Next Year | $5.58 | N/A |
| P/E Ratio | $17.79 | ★ N/A |
| Revenue Growth | ★ 23.09 | N/A |
| 52 Week Low | $17.40 | $13.88 |
| 52 Week High | $26.50 | $27.31 |
Technical Indicators
Market Signals| Indicator | SPNT | DYN |
|---|---|---|
| Relative Strength Index (RSI) | 62.76 | 33.38 |
| Support Level | $22.22 | $14.34 |
| Resistance Level | $26.49 | $19.54 |
| Average True Range (ATR) | 0.59 | 0.75 |
| MACD | 0.02 | 0.31 |
| Stochastic Oscillator | 57.92 | 40.25 |
Price Performance
Historical ComparisonAbout SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.